Ignite Creation Date:
2025-12-24 @ 9:37 PM
Ignite Modification Date:
2025-12-25 @ 7:20 PM
Study NCT ID:
NCT04228432
Status:
COMPLETED
Last Update Posted:
2021-07-27
First Post:
2020-01-10
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer.
Sponsor:
Institut Claudius Regaud
Organization:
Study Overview
Official Title:
E-monitoring of Patients Under Adjuvant Hormonotherapy for Breast Cancer: Pilot Study
Status:
COMPLETED
Status Verified Date:
2021-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
EPOPEE
Brief Summary:
This is a monocentric, prospective cohort study evaluating the feasibility of an E-monitoring protocol in patients with breast cancer treated by adjuvant hormonotherapy .
45 patients will be included.
Patients will be followed during 6 months.
45 patients will be included.
Patients will be followed during 6 months.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: